Hee Chul Park
Papers
2
Total Citations
35
H-Index
2
About
Hee Chul Park is a distinguished radiation oncologist whose research bridges the critical gap between advanced treatment technologies and improved patient outcomes. His primary research areas include gastrointestinal oncology, particularly rectal cancer, and the development of innovative safety systems for proton therapy. Dr. Park made a landmark contribution with his phase II multi-institutional clinical trial (KROG 11-02), which demonstrated the efficacy of a two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer, a study that has garnered 25 citations and helped shape neoadjuvant treatment paradigms. In the realm of proton therapy, he pioneered a virtual simulator designed for collision prevention, addressing a critical safety challenge where the large nozzle structure risks patient contact during treatment. This software, cited 10 times, predicts and prevents collisions between the nozzle and patient by optimizing treatment positioning and minimizing air gaps. Dr. Park’s work exemplifies the integration of clinical trial evidence with cutting-edge physics-based solutions, making him a key figure in advancing both the safety and efficacy of modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2A virtual simulator designed for collision prevention in proton therapy10 citations · 2015